Your browser doesn't support javascript.
loading
Treatment of Radiation-Induced Cognitive Decline in Adult Brain Tumor Patients.
Cramer, Christina K; Cummings, Tiffany L; Andrews, Rachel N; Strowd, Roy; Rapp, Stephen R; Shaw, Edward G; Chan, Michael D; Lesser, Glenn J.
Afiliação
  • Cramer CK; Department of Radiation Oncology, Wake Forest Baptist Medical Center, Medical Center Blvd, Winston-Salem, NC, 27157, USA. ccramer@wakehealth.edu.
  • Cummings TL; Department of Neurology, Wake Forest Baptist Medical Center, Winston-Salem, NC, 27157, USA.
  • Andrews RN; Department of Radiation Oncology, Section on Radiation Biology, Wake Forest Baptist Medical Center, Medical Center Blvd, Winston-Salem, NC, 27157, USA.
  • Strowd R; Department of Hematology/Oncology, Wake Forest Baptist Medical Center, Winston-Salem, NC, 27157, USA.
  • Rapp SR; Department of Psychiatry and Behavioral Medicine and Division Public Health Sciences (Social Sciences and Health Policy), Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC, USA.
  • Shaw EG; Memory Counseling Program, Section on Gerontology and Geriatric Medicine, Sticht Center on Healthy Aging and Alzheimer's Prevention, Wake Forest Baptist Health, Medical Center Boulevard, Winston-Salem, NC, 27157, USA.
  • Chan MD; Department of Radiation Oncology, Wake Forest Baptist Medical Center, Medical Center Blvd, Winston-Salem, NC, 27157, USA.
  • Lesser GJ; Oncology, Medical Neuro-Oncology and Neuro-Oncology Research Program, Wake Forest Baptist Comprehensive Cancer Center, Medical Center Boulevard, Winston-Salem, NC, 27157-1082, USA.
Curr Treat Options Oncol ; 20(5): 42, 2019 04 08.
Article em En | MEDLINE | ID: mdl-30963289
OPINION STATEMENT: Patients with either primary or metastatic brain tumors quite often have cognitive impairment. Maintaining cognitive function is important to brain tumor patients and a decline in cognitive function is generally accompanied by a decline in functional independence and performance status. Cognitive decline can be a result of tumor progression, depression/anxiety, fatigue/sleep dysfunction, or the treatments they have received. It is our opinion that providers treating brain tumor patients should obtain pre-treatment and serial cognitive testing in their patients and offer mitigating and therapeutic interventions when appropriate. They should also support cognition-focused clinical trials.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Cuidados_paliativos / Geral / Prevencao_e_fatores_de_risco / Agentes_cancerigenos / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Radioterapia / Neoplasias Encefálicas / Disfunção Cognitiva Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Curr Treat Options Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Cuidados_paliativos / Geral / Prevencao_e_fatores_de_risco / Agentes_cancerigenos / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Radioterapia / Neoplasias Encefálicas / Disfunção Cognitiva Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Curr Treat Options Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos